首页 > 最新文献

Arkhiv patologii最新文献

英文 中文
[Metastases of endometrioid adenocarcinoma of the endometrium in the mammary gland and axillary lymph nodes]. 【子宫内膜样腺癌在乳腺和腋窝淋巴结的转移】。
Q4 Medicine Pub Date : 2026-01-01 DOI: 10.17116/patol20268801168
B N Isic, E M Bit-Sava, A O Damenia, V A Kheinshtein

Breast tumors are one of the most common locations of malignant neoplasms. Every year, new aspects of the pathogenesis of breast cancer are discovered; along with genetic, hormonal and other factors, the issue of implantation and metastatic damage to the organ by tumors of other localizations is being increasingly discussed. With evolving diagnostic methods, more and more reports are emerging indicating that sometimes a breast tumor is not a primary lesion, but a site of metastasis. In this paper, the authors present a clinical case of metastasis of endometrioid adenocarcinoma of the endometrium to the breast. In this paper, the authors present a clinical case of metastasis of endometrioid adenocarcinoma of the endometrium to the mammary gland. The final diagnosis was made through analysis of a combination of morphological and immunohistochemical features. This clinical case is unique from a clinical and pathological perspective.

乳腺肿瘤是恶性肿瘤最常见的部位之一。每年都有关于乳腺癌发病机制的新发现;随着遗传、激素和其他因素的影响,其他部位的肿瘤对器官的植入和转移性损伤问题正在越来越多地被讨论。随着诊断方法的发展,越来越多的报道表明,有时乳房肿瘤不是原发病变,而是转移部位。本文报告一例子宫内膜样腺癌向乳腺转移的临床病例。本文报告一例子宫内膜样腺癌向乳腺转移的临床病例。通过结合形态学和免疫组织化学特征进行最终诊断。从临床和病理角度来看,该病例是独特的。
{"title":"[Metastases of endometrioid adenocarcinoma of the endometrium in the mammary gland and axillary lymph nodes].","authors":"B N Isic, E M Bit-Sava, A O Damenia, V A Kheinshtein","doi":"10.17116/patol20268801168","DOIUrl":"10.17116/patol20268801168","url":null,"abstract":"<p><p>Breast tumors are one of the most common locations of malignant neoplasms. Every year, new aspects of the pathogenesis of breast cancer are discovered; along with genetic, hormonal and other factors, the issue of implantation and metastatic damage to the organ by tumors of other localizations is being increasingly discussed. With evolving diagnostic methods, more and more reports are emerging indicating that sometimes a breast tumor is not a primary lesion, but a site of metastasis. In this paper, the authors present a clinical case of metastasis of endometrioid adenocarcinoma of the endometrium to the breast. In this paper, the authors present a clinical case of metastasis of endometrioid adenocarcinoma of the endometrium to the mammary gland. The final diagnosis was made through analysis of a combination of morphological and immunohistochemical features. This clinical case is unique from a clinical and pathological perspective.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"88 1","pages":"68-72"},"PeriodicalIF":0.0,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146050011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[DDAH1 protein: biological functions, role in carcinogenesis processes]. [DDAH1蛋白:生物学功能,在癌变过程中的作用]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258701160
E A Prosekina, V A Shapkina, A E Karpov, E Yu Fedorutseva, A S Artemyeva

Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) is an essential enzyme capable of degrading asymmetric dimethylarginine, which is an endogenous inhibitor of nitric oxide synthase. Increased expression of DDAH1 and subsequent increased NO production are associated with carcinogenesis. In particular, DDAH1 is involved in the creation of a vascular network by tumor cells, vasculogenic mimicry, which is closely associated with tumor progression and poor patient prognosis. This is the reason why DDAH1 may be a potential therapeutic target for the treatment of cancer.

二甲基精氨酸二甲基氨基水解酶1 (Dimethylaminohydrolase 1, DDAH1)是一种能够降解内源性一氧化氮合酶抑制剂——不对称二甲基精氨酸的必需酶。DDAH1表达的增加和随后NO生成的增加与癌变有关。特别是,DDAH1参与肿瘤细胞形成血管网络,血管源性拟态,这与肿瘤进展和患者预后不良密切相关。这就是为什么DDAH1可能成为治疗癌症的潜在治疗靶点的原因。
{"title":"[DDAH1 protein: biological functions, role in carcinogenesis processes].","authors":"E A Prosekina, V A Shapkina, A E Karpov, E Yu Fedorutseva, A S Artemyeva","doi":"10.17116/patol20258701160","DOIUrl":"10.17116/patol20258701160","url":null,"abstract":"<p><p>Dimethylarginine Dimethylaminohydrolase 1 (DDAH1) is an essential enzyme capable of degrading asymmetric dimethylarginine, which is an endogenous inhibitor of nitric oxide synthase. Increased expression of DDAH1 and subsequent increased NO production are associated with carcinogenesis. In particular, DDAH1 is involved in the creation of a vascular network by tumor cells, vasculogenic mimicry, which is closely associated with tumor progression and poor patient prognosis. This is the reason why DDAH1 may be a potential therapeutic target for the treatment of cancer.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 1","pages":"60-67"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prostate involvement in granulomatosis with polyangiitis]. [肉芽肿伴多血管炎累及前列腺]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258703182
A S Kontorshchikov, V V Pechnikova, A L Chernyaev, M V Samsonova, D G Karelidze, L M Mikhaleva

Granulomatosis with polyangiitis (Wegener's granulomatosis, ANCA-associated vasculitis) is a rare systemic disease with unclear etiology, raising many questions in the interpretation of changes in internal organs during computed tomography and the assessment of diagnostic signs during pathohistological examination of biopsy/autopsy material. This paper describes a rare clinical observation of granulomatosis with polyangiitis in a 62-year-old patient with lung, kidney, and prostate lesions.

肉芽肿病合并多血管炎(Wegener肉芽肿病,anca相关性血管炎)是一种罕见的全体性疾病,病因不明,在计算机断层扫描中对内脏器官变化的解释以及活检/尸检材料病理组织学检查中诊断征象的评估方面提出了许多问题。本文报告一个罕见的临床观察肉芽肿病合并多血管炎在62岁的病人肺,肾和前列腺病变。
{"title":"[Prostate involvement in granulomatosis with polyangiitis].","authors":"A S Kontorshchikov, V V Pechnikova, A L Chernyaev, M V Samsonova, D G Karelidze, L M Mikhaleva","doi":"10.17116/patol20258703182","DOIUrl":"https://doi.org/10.17116/patol20258703182","url":null,"abstract":"<p><p>Granulomatosis with polyangiitis (Wegener's granulomatosis, ANCA-associated vasculitis) is a rare systemic disease with unclear etiology, raising many questions in the interpretation of changes in internal organs during computed tomography and the assessment of diagnostic signs during pathohistological examination of biopsy/autopsy material. This paper describes a rare clinical observation of granulomatosis with polyangiitis in a 62-year-old patient with lung, kidney, and prostate lesions.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 3","pages":"82-87"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The structure of causes of death of the adult population of the Moscow region in 2019 and 2023]. [2019年和2023年莫斯科地区成年人口死亡原因结构]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258703140
E P Kakorina, I V Samorodskaya

Objective: To compare the structure of causes of death among men and women of different age groups in 2019 and 2023 (using the Moscow Region as an example).

Material and methods: Anonymized personalized data from medical death certificates (MDC) of the database of the Main Civil Registry Office in the Moscow Region. A total of 87.555 MDCs in 2019 and 92.182 in 2023 of persons aged 18 years and older. The absolute number of deaths (total and in ten-year age groups), the contribution of disease classes according to ICD-10 were determined, a comparison of unstandardized mortality rates (UR) and the structure of causes of death was carried out.

Results: The mortality rate for men (18 years and older) was 1499 per 100.000 men in 2019 and 1434 in 2023; for women - 1367 and 1344, respectively. The UR of men is higher than that of women up to the age of 80, with the greatest differences at the age of 18-39 years. An increase in the number of deaths, UR and contribution to the mortality structure in men and women was noted for 5 ICD classes (E, J, K, N and S-T in men); a decrease was found for class F, for women - for 2 classes (G and R). The most significant differences in the UR and structure of causes of death in men and women are associated with four classes (S-T, J, E and G). The smallest changes were recorded for the class of neoplasms (about 15% of deaths in both men and women in 2019 and in 2023). A high proportion of poorly defined codes was noted (for example, more than 80% in the class of nervous diseases are accounted for by 3 codes G31.1, G93.0 and G93.4). The differences and changes identified in the structure of causes of death in 10-year age groups of men and women are likely largely due to controversial issues regarding the determination of the underlying cause of death.

Conclusion: Mortality reduction strategies should take into account age-sex characteristics of causes of death. Significant changes in UR from individual causes and a sharp increase in the proportion of deaths with codes that have no clinical analogues in old age require improvement of approaches to indicating and coding causes of death.

目的:比较2019年和2023年不同年龄段男性和女性的死亡原因结构(以莫斯科州为例)。材料和方法:来自莫斯科州主要民事登记处数据库的医疗死亡证明(MDC)的匿名个人数据。在18岁及以上的人群中,2019年共有87.555例MDCs, 2023年为92.182例。确定了绝对死亡人数(总死亡人数和10岁年龄组死亡人数)、疾病类别对《国际疾病分类-10》的贡献,并对非标准化死亡率(UR)和死亡原因结构进行了比较。结果:2019年男性(18岁及以上)死亡率为1499 / 10万,2023年为1434 / 10万;女性分别是1367和1344。80岁之前,男性UR高于女性,18-39岁年龄段差异最大。注意到5类国际疾病分类(男性的E、J、K、N和S-T)中男性和女性的死亡人数、UR和对死亡率结构的贡献有所增加;在F类女性中,有两个类(G和R)的发病率有所下降。男女尿路和死亡原因结构的最显著差异与四类(S-T、J、E和G)有关。肿瘤类别的变化最小(2019年和2023年约占男性和女性死亡人数的15%)。报告指出,定义不清的编码比例很高(例如,超过80%的神经疾病由G31.1、G93.0和G93.4三个编码组成)。在10岁年龄组男女死亡原因结构中发现的差异和变化,可能主要是由于在确定根本死亡原因方面存在争议问题。结论:降低死亡率的策略应考虑到死亡原因的年龄-性别特征。个体原因导致尿路的显著变化,以及老年患者没有临床类似物编码的死亡比例的急剧增加,需要改进指示和编码死亡原因的方法。
{"title":"[The structure of causes of death of the adult population of the Moscow region in 2019 and 2023].","authors":"E P Kakorina, I V Samorodskaya","doi":"10.17116/patol20258703140","DOIUrl":"10.17116/patol20258703140","url":null,"abstract":"<p><strong>Objective: </strong>To compare the structure of causes of death among men and women of different age groups in 2019 and 2023 (using the Moscow Region as an example).</p><p><strong>Material and methods: </strong>Anonymized personalized data from medical death certificates (MDC) of the database of the Main Civil Registry Office in the Moscow Region. A total of 87.555 MDCs in 2019 and 92.182 in 2023 of persons aged 18 years and older. The absolute number of deaths (total and in ten-year age groups), the contribution of disease classes according to ICD-10 were determined, a comparison of unstandardized mortality rates (UR) and the structure of causes of death was carried out.</p><p><strong>Results: </strong>The mortality rate for men (18 years and older) was 1499 per 100.000 men in 2019 and 1434 in 2023; for women - 1367 and 1344, respectively. The UR of men is higher than that of women up to the age of 80, with the greatest differences at the age of 18-39 years. An increase in the number of deaths, UR and contribution to the mortality structure in men and women was noted for 5 ICD classes (E, J, K, N and S-T in men); a decrease was found for class F, for women - for 2 classes (G and R). The most significant differences in the UR and structure of causes of death in men and women are associated with four classes (S-T, J, E and G). The smallest changes were recorded for the class of neoplasms (about 15% of deaths in both men and women in 2019 and in 2023). A high proportion of poorly defined codes was noted (for example, more than 80% in the class of nervous diseases are accounted for by 3 codes G31.1, G93.0 and G93.4). The differences and changes identified in the structure of causes of death in 10-year age groups of men and women are likely largely due to controversial issues regarding the determination of the underlying cause of death.</p><p><strong>Conclusion: </strong>Mortality reduction strategies should take into account age-sex characteristics of causes of death. Significant changes in UR from individual causes and a sharp increase in the proportion of deaths with codes that have no clinical analogues in old age require improvement of approaches to indicating and coding causes of death.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 3","pages":"40-48"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144324391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[On the 60th anniversary of the P. Lauren's classification of histological types of gastric cancer]. [P. Lauren胃癌组织学分型60周年纪念]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258704168
N V Danilova, O D Bunga, P G Malkov

The epidemiological data on the incidence of gastric cancer and its mortality make it a challenge for oncologists to find new and improve existing diagnostic methods and therapies. Despite the active change of modern realities in the practice of pathomorphologist for 60 years remains unchanged authority of the P.Laurén classification of histological main types. This does not leave it without attention from the scientists of our time, so there are published works refuting or confirming its prognostic significance, as well as studies in which its modifications are proposed. In this regard, the purpose of this review is to briefly systematise the currently available information on P.Laurén classification and to provide an opportunity to review the content of the original article by Pekka Laurén in Russian.

胃癌发病率和死亡率的流行病学数据对肿瘤学家提出了新的和改进现有诊断方法和治疗方法的挑战。尽管病理形态学家的实践在现代现实中发生了积极的变化,但60年来p.l awassen对组织学主要类型的分类仍然保持不变。这并没有使它不受到我们这个时代科学家的关注,所以有出版的作品反驳或确认它的预测意义,以及提出修改的研究。在这方面,这次审查的目的是简要地整理目前关于p.l lathryn分类的现有资料,并提供机会审查Pekka laurthryn的俄文原文章的内容。
{"title":"[On the 60th anniversary of the P. Lauren's classification of histological types of gastric cancer].","authors":"N V Danilova, O D Bunga, P G Malkov","doi":"10.17116/patol20258704168","DOIUrl":"10.17116/patol20258704168","url":null,"abstract":"<p><p>The epidemiological data on the incidence of gastric cancer and its mortality make it a challenge for oncologists to find new and improve existing diagnostic methods and therapies. Despite the active change of modern realities in the practice of pathomorphologist for 60 years remains unchanged authority of the P.Laurén classification of histological main types. This does not leave it without attention from the scientists of our time, so there are published works refuting or confirming its prognostic significance, as well as studies in which its modifications are proposed. In this regard, the purpose of this review is to briefly systematise the currently available information on P.Laurén classification and to provide an opportunity to review the content of the original article by Pekka Laurén in Russian.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 4","pages":"68-75"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144940488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Aberrant TTF1 expression in anaplastic large cell lymphoma]. TTF1在间变性大细胞淋巴瘤中的异常表达。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol2025870515
V A Khorzhevskii, S V Gappoev, Y S Kanin, E V Alymova, I V Vershinin, A A Kozireva

Thyroid transcription factor 1 (TTF1) is the most common and reliable marker for immunohistochemical diagnostics of various thyroid tumors and lung adenocarcinoma. At the same time, some of scientific studies have been published that describe aberrant expression of TTF1 by cells of various tumors, including lymphomas. Researchers reported the possibility of TTF1 expression in diffuse large B-cell lymphoma, angioimmunoblastic T-cell lymphoma, and T-cell leukemia. However, there were no reports of this marker expression in anaplastic large cell lymphoma, which, due to its morphological characteristics, may resemble a metastatic process.

Objective: To assess the frequency of aberrant expression of TTF1 in anaplastic large cell lymphoma cells.

Material and methods: The study was performed on 47 cases of anaplastic large cell lymphoma. The expression of TTF1 was assessed using two different platforms (Ventana BenchMark ULTRA and BondMAX) and two different, commercially available, clones (SP141, SPT24), including the use of a double chromogenic label.

Results: The study detected the expression of TTF1 by tumor cells in five cases (10.6%) of nodal ALK-negative anaplastic large cell lymphoma in patients with a median age of 66 years, with a TTF1 expression gradient from 100% to 15% of tumor cells.

Conclusion: The study demonstrated for the first time the possibility of aberrant expression of TTF1 by anaplastic large cell lymphoma cells. In one case, intense expression of TTF1 was observed in 100% of tumor cells, in the rest - in no more than 15%. Moreover, expression was observed both in cases of using clone SP141 and clone SPT24. In our opinion, the identified aberrant expression of TTF1 in anaplastic large cell lymphoma, may cause an error in the morphological diagnosis of the metastatic process and requires additional attention from the pathologist.

甲状腺转录因子1 (TTF1)是各种甲状腺肿瘤和肺腺癌免疫组化诊断中最常见、最可靠的标志物。与此同时,一些科学研究已经发表,描述了包括淋巴瘤在内的各种肿瘤细胞中TTF1的异常表达。研究人员报道了TTF1在弥漫性大b细胞淋巴瘤、血管免疫母细胞t细胞淋巴瘤和t细胞白血病中表达的可能性。然而,该标记在间变性大细胞淋巴瘤中没有表达的报道,由于其形态学特征,可能类似于转移过程。目的:探讨TTF1在间变性大细胞淋巴瘤细胞中的异常表达频率。材料与方法:对47例间变性大细胞淋巴瘤进行研究。使用两种不同的平台(Ventana BenchMark ULTRA和BondMAX)和两种不同的市售克隆(SP141, SPT24)评估TTF1的表达,包括使用双显色标记。结果:本研究在5例(10.6%)淋巴结alk阴性间变性大细胞淋巴瘤患者(中位年龄66岁)中检测到TTF1在肿瘤细胞中的表达,TTF1在肿瘤细胞中的表达梯度为100% ~ 15%。结论:本研究首次证实了TTF1在间变性大细胞淋巴瘤细胞中异常表达的可能性。在一个病例中,100%的肿瘤细胞中观察到TTF1的强烈表达,而在其他病例中,不超过15%。此外,克隆SP141和克隆SPT24均有表达。我们认为TTF1在间变性大细胞淋巴瘤中的异常表达可能会导致转移过程的形态学诊断错误,需要病理学家给予额外的关注。
{"title":"[Aberrant TTF1 expression in anaplastic large cell lymphoma].","authors":"V A Khorzhevskii, S V Gappoev, Y S Kanin, E V Alymova, I V Vershinin, A A Kozireva","doi":"10.17116/patol2025870515","DOIUrl":"https://doi.org/10.17116/patol2025870515","url":null,"abstract":"<p><p>Thyroid transcription factor 1 (TTF1) is the most common and reliable marker for immunohistochemical diagnostics of various thyroid tumors and lung adenocarcinoma. At the same time, some of scientific studies have been published that describe aberrant expression of TTF1 by cells of various tumors, including lymphomas. Researchers reported the possibility of TTF1 expression in diffuse large B-cell lymphoma, angioimmunoblastic T-cell lymphoma, and T-cell leukemia. However, there were no reports of this marker expression in anaplastic large cell lymphoma, which, due to its morphological characteristics, may resemble a metastatic process.</p><p><strong>Objective: </strong>To assess the frequency of aberrant expression of TTF1 in anaplastic large cell lymphoma cells.</p><p><strong>Material and methods: </strong>The study was performed on 47 cases of anaplastic large cell lymphoma. The expression of TTF1 was assessed using two different platforms (Ventana BenchMark ULTRA and BondMAX) and two different, commercially available, clones (SP141, SPT24), including the use of a double chromogenic label.</p><p><strong>Results: </strong>The study detected the expression of TTF1 by tumor cells in five cases (10.6%) of nodal ALK-negative anaplastic large cell lymphoma in patients with a median age of 66 years, with a TTF1 expression gradient from 100% to 15% of tumor cells.</p><p><strong>Conclusion: </strong>The study demonstrated for the first time the possibility of aberrant expression of TTF1 by anaplastic large cell lymphoma cells. In one case, intense expression of TTF1 was observed in 100% of tumor cells, in the rest - in no more than 15%. Moreover, expression was observed both in cases of using clone SP141 and clone SPT24. In our opinion, the identified aberrant expression of TTF1 in anaplastic large cell lymphoma, may cause an error in the morphological diagnosis of the metastatic process and requires additional attention from the pathologist.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 5","pages":"5-10"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145375885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The immune status of the endometrium in patients with abnormal uterine bleeding associated with chronic endometritis]. [慢性子宫内膜炎伴异常子宫出血患者子宫内膜免疫状况]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258705120
L M Mikhaleva, R Y Mitrelis, M R Orazov, V E Radzinsky, S A Mikhalev, R A Vandysheva, D N Masalimova, T Y Kobyzeva, E G Homskaya

Chronic endometritis is widespread among women of reproductive age, it can be the cause of menstrual disorders, abnormal uterine bleeding and, finally, infertility of uterine genesis. The issue of impaired immune status of the glandular-stromal component in chronic endometritis has not been deeply investigated. Violation of the ratio of immune system cells is a fundamental link in the development of imbalance of the immunological status of the endometrium.

Objective: To present a comparative analysis of the immune status of the endometrium in patients with abnormal uterine bleeding associated with chronic endometritis of varying severity.

Material and methods: A comparative analysis of clinical data, histological and immunohistochemical results of endometrial examination in 95 patients of reproductive age was carried out. Diagnosis of chronic endometritis was performed in histological sections: immunohistochemical reaction with CD138 antibodies with assessment of the number of plasma cells. In addition, the presence or absence of endometrial stromal fibrosis was recorded using Mallory staining. The following markers of endometrial lymphocytes were counted: CD4, CD8, CD20, CD56, and the CD4/CD8 ratio was estimated.

Results: The morphological sign indicating changes in the immune status in patients with abnormal uterine bleeding associated with chronic endometritis is a significant increase in the number of lymphocytes characterised by increased expression of CD4, CD8, CD20, CD56 markers, and a disruption of the CD4/CD8 ratio, directly proportional to the degree of severity of chronic endometritis.

Conclusion: The study demonstrates statistically significant differences in immune status in patients with abnormal uterine bleeding associated with chronic endometritis of varying severity. Local immunity cells in the endometrium coordinate the menstrual cycle, and their imbalance leads to the activation of pathological mechanisms of endometrial immunoregulation, which is probably a pathogenetic factor of functional failure of the endometrium and menstrual disorders in women.

慢性子宫内膜炎广泛存在于育龄妇女中,它可以引起月经紊乱,子宫异常出血,最终导致子宫发生性不孕。慢性子宫内膜炎中腺体间质成分的免疫状态受损问题尚未深入研究。免疫系统细胞比例失调是子宫内膜免疫状态失衡发展的根本环节。目的:比较分析不同程度慢性子宫内膜炎伴异常子宫出血患者的子宫内膜免疫状态。材料与方法:对95例育龄期子宫内膜检查的临床资料、组织学及免疫组化结果进行对比分析。病理切片诊断慢性子宫内膜炎:CD138抗体免疫组化反应并评估浆细胞数量。此外,使用Mallory染色记录子宫内膜间质纤维化的存在或不存在。计数子宫内膜淋巴细胞的以下标记物:CD4、CD8、CD20、CD56,并估计CD4/CD8比值。结果:慢性子宫内膜炎相关子宫异常出血患者免疫状态变化的形态学标志是淋巴细胞数量显著增加,CD4、CD8、CD20、CD56标记物表达增加,CD4/CD8比值破坏,与慢性子宫内膜炎的严重程度成正比。结论:本研究显示不同严重程度的慢性子宫内膜炎伴异常子宫出血患者的免疫状态存在统计学差异。子宫内膜局部免疫细胞协调月经周期,其失衡导致子宫内膜免疫调节的病理机制被激活,这可能是女性子宫内膜功能衰竭和月经紊乱的致病因素。
{"title":"[The immune status of the endometrium in patients with abnormal uterine bleeding associated with chronic endometritis].","authors":"L M Mikhaleva, R Y Mitrelis, M R Orazov, V E Radzinsky, S A Mikhalev, R A Vandysheva, D N Masalimova, T Y Kobyzeva, E G Homskaya","doi":"10.17116/patol20258705120","DOIUrl":"https://doi.org/10.17116/patol20258705120","url":null,"abstract":"<p><p>Chronic endometritis is widespread among women of reproductive age, it can be the cause of menstrual disorders, abnormal uterine bleeding and, finally, infertility of uterine genesis. The issue of impaired immune status of the glandular-stromal component in chronic endometritis has not been deeply investigated. Violation of the ratio of immune system cells is a fundamental link in the development of imbalance of the immunological status of the endometrium.</p><p><strong>Objective: </strong>To present a comparative analysis of the immune status of the endometrium in patients with abnormal uterine bleeding associated with chronic endometritis of varying severity.</p><p><strong>Material and methods: </strong>A comparative analysis of clinical data, histological and immunohistochemical results of endometrial examination in 95 patients of reproductive age was carried out. Diagnosis of chronic endometritis was performed in histological sections: immunohistochemical reaction with CD138 antibodies with assessment of the number of plasma cells. In addition, the presence or absence of endometrial stromal fibrosis was recorded using Mallory staining. The following markers of endometrial lymphocytes were counted: CD4, CD8, CD20, CD56, and the CD4/CD8 ratio was estimated.</p><p><strong>Results: </strong>The morphological sign indicating changes in the immune status in patients with abnormal uterine bleeding associated with chronic endometritis is a significant increase in the number of lymphocytes characterised by increased expression of CD4, CD8, CD20, CD56 markers, and a disruption of the CD4/CD8 ratio, directly proportional to the degree of severity of chronic endometritis.</p><p><strong>Conclusion: </strong>The study demonstrates statistically significant differences in immune status in patients with abnormal uterine bleeding associated with chronic endometritis of varying severity. Local immunity cells in the endometrium coordinate the menstrual cycle, and their imbalance leads to the activation of pathological mechanisms of endometrial immunoregulation, which is probably a pathogenetic factor of functional failure of the endometrium and menstrual disorders in women.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 5","pages":"20-27"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145375920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Sex cord tumor with annular tubules]. [伴环状小管的性索肿瘤]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258701148
A S Badlaeva, A V Tregubova, R B Matronitskii, A P Raksha, V V Sukhoparova, N L Lysova, A V Asaturova

Sex cord tumor with annular tubules is a rare type of ovarian tumor, which seems to arise from Sertoli cells. Most tumors are associated with Peutz-Jeghers syndrome and have a benign course and favorable prognosis; however, about 20% of sporadic sex cord tumors with annular tubules have a high risk of developing metastases. We present a case report about 18-year-old patient who presented with irregular menstruation and abdominal pain. Based on the histological features and immunohistochemical results, the diagnosis of a sex cord tumor with annular tubules was confirmed. The above-described ovarian tumor is rare in childhood and adolescence compared to the general population, which, combined with nonspecific clinical manifestations, can result certain diagnostic difficulties in this age group of patients.

环状小管性索肿瘤是一种罕见的卵巢肿瘤,似乎起源于支持细胞。大多数肿瘤与Peutz-Jeghers综合征相关,病程良好,预后良好;然而,约20%的散发性索环状小管肿瘤有很高的转移风险。我们报告了一例18岁的患者,其表现为月经不调和腹痛。根据组织学特征和免疫组化结果,确诊为有性索肿瘤伴环状小管。与一般人群相比,上述卵巢肿瘤在儿童和青少年中很少见,这与非特异性临床表现相结合,可能导致该年龄组患者的某些诊断困难。
{"title":"[Sex cord tumor with annular tubules].","authors":"A S Badlaeva, A V Tregubova, R B Matronitskii, A P Raksha, V V Sukhoparova, N L Lysova, A V Asaturova","doi":"10.17116/patol20258701148","DOIUrl":"10.17116/patol20258701148","url":null,"abstract":"<p><p>Sex cord tumor with annular tubules is a rare type of ovarian tumor, which seems to arise from Sertoli cells. Most tumors are associated with Peutz<i>-</i>Jeghers syndrome and have a benign course and favorable prognosis; however, about 20% of sporadic sex cord tumors with annular tubules have a high risk of developing metastases. We present a case report about 18-year-old patient who presented with irregular menstruation and abdominal pain. Based on the histological features and immunohistochemical results, the diagnosis of a sex cord tumor with annular tubules was confirmed. The above-described ovarian tumor is rare in childhood and adolescence compared to the general population, which, combined with nonspecific clinical manifestations, can result certain diagnostic difficulties in this age group of patients.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 1","pages":"48-52"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative analysis of EGFR gene mutations (exon 20) in sinonasal papillomas of inverted and oncocytic types]. [倒置型和嗜瘤型鼻窦乳头瘤中EGFR基因(外显子20)突变的比较分析]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258701116
A A Bakhtin, N A Dykhes, O V Karneeva, E L Tumanova, A A Kazakov, V V Demkin, O A Sapegina

Sinonasal papillomas are a group of benign, relatively rare tumors of the sinonasal tract with varying clinical courses. In the modern WHO classification, it is customary to distinguish three subtypes of sinonasal papillomas: the most common inverted type (ISP), oncocytic type (OSP) and exophytic type (ESP). Recently, the concept has emerged that the different types of sinonasal papillomas may not be variants of a single tumor, but rather separate tumors. Thus, OSP demonstrates KRAS mutations, and the pathogenesis of ISP is associated with EGFR mutations.

Objective: To provide a comparative description of the EGFR gene (exon 20) based on the results of Sanger sequencing in sinonasal papillomas of inverted and oncocytic types.

Material and methods: Sanger sequencing of the EGFR gene (exon 20) was performed in 83 cases of sinonasal papillomas, of which 17 were of OSP and 66 were ISP cases. In 20 cases, an additional immunohistochemical study with an antibody to EGFR was also performed.

Results: When sequencing by Sanger of exon 20 of the EGFR gene in the ISP group, missense mutations were identified in 16 out of 66 cases, leading to a change in the value of the coding sequence of the gene, ultimately determining the formation of a different amino acid; this type of mutation was not identified in the OSP group. The most common mutation was at position 2622 in the form of G to A transition: in 47 cases of ISP (70%) and in 12 cases of OSP (71%). This mutation was synonymous and did not lead to an amino acid replacement in the synthesized protein. Thus, we did not find any significant differences in exon 20 of the EGFR gene between the ISP and OSP groups. In the ISP group, in 48 of 66 cases, multiple and single point mutations were noted, which we characterize as genetic heterogeneity.

摘要鼻乳头状瘤是一组相对罕见的良性鼻道肿瘤,其临床病程各不相同。在现代WHO分类中,通常将鼻乳头瘤分为三种亚型:最常见的倒型(ISP)、嗜瘤细胞型(OSP)和外生性型(ESP)。最近出现了一种概念,即不同类型的鼻窦乳头状瘤可能不是单一肿瘤的变体,而是不同的肿瘤。因此,OSP表现出KRAS突变,而ISP的发病机制与EGFR突变有关。目的:基于Sanger测序结果,对倒置型和嗜瘤型鼻窦乳头瘤中EGFR基因(外显子20)进行比较描述。材料与方法:对83例鼻窦乳头状瘤患者进行EGFR基因(外显子20)Sanger测序,其中OSP患者17例,ISP患者66例。在20例中,还进行了额外的EGFR抗体免疫组织化学研究。结果:对ISP组EGFR基因外显子20进行Sanger测序时,66例中有16例发现错义突变,导致基因编码序列的值发生变化,最终决定了不同氨基酸的形成;在OSP组中未发现这种类型的突变。最常见的突变发生在2622位点,以G到A的转变形式出现:47例ISP(70%)和12例OSP(71%)。这种突变是同义的,不会导致合成蛋白质中的氨基酸替换。因此,我们没有发现ISP组和OSP组之间EGFR基因外显子20有任何显著差异。在ISP组中,66例中有48例存在多点和单点突变,我们将其描述为遗传异质性。
{"title":"[Comparative analysis of EGFR gene mutations (exon 20) in sinonasal papillomas of inverted and oncocytic types].","authors":"A A Bakhtin, N A Dykhes, O V Karneeva, E L Tumanova, A A Kazakov, V V Demkin, O A Sapegina","doi":"10.17116/patol20258701116","DOIUrl":"10.17116/patol20258701116","url":null,"abstract":"<p><p>Sinonasal papillomas are a group of benign, relatively rare tumors of the sinonasal tract with varying clinical courses. In the modern WHO classification, it is customary to distinguish three subtypes of sinonasal papillomas: the most common inverted type (ISP), oncocytic type (OSP) and exophytic type (ESP). Recently, the concept has emerged that the different types of sinonasal papillomas may not be variants of a single tumor, but rather separate tumors. Thus, OSP demonstrates <i>KRAS</i> mutations, and the pathogenesis of ISP is associated with <i>EGFR</i> mutations.</p><p><strong>Objective: </strong>To provide a comparative description of the <i>EGFR</i> gene (exon 20) based on the results of Sanger sequencing in sinonasal papillomas of inverted and oncocytic types.</p><p><strong>Material and methods: </strong>Sanger sequencing of the <i>EGFR</i> gene (exon 20) was performed in 83 cases of sinonasal papillomas, of which 17 were of OSP and 66 were ISP cases. In 20 cases, an additional immunohistochemical study with an antibody to EGFR was also performed.</p><p><strong>Results: </strong>When sequencing by Sanger of exon 20 of the <i>EGFR</i> gene in the ISP group, missense mutations were identified in 16 out of 66 cases, leading to a change in the value of the coding sequence of the gene, ultimately determining the formation of a different amino acid; this type of mutation was not identified in the OSP group. The most common mutation was at position 2622 in the form of G to A transition: in 47 cases of ISP (70%) and in 12 cases of OSP (71%). This mutation was synonymous and did not lead to an amino acid replacement in the synthesized protein. Thus, we did not find any significant differences in exon 20 of the EGFR gene between the ISP and OSP groups. In the ISP group, in 48 of 66 cases, multiple and single point mutations were noted, which we characterize as genetic heterogeneity.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 1","pages":"16-21"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143405572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Post-Covid aortitis with cardiac involvement: progressive aortic aneurysm combined with active myocarditis]. [冠状病毒后主动脉炎累及心脏:进行性主动脉瘤合并活动性心肌炎]。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.17116/patol20258702153
O V Blagova, P O Savina, E A Kogan

The new coronavirus infection is characterized not only by pronounced cytokine and autoimmune reactions in the acute period, but is also an inducer of a whole spectrum of chronic immunoinflammatory conditions, which differ in varying degrees of specificity from general manifestations of the so-called post-COVID syndrome to single-organ diseases (including myocarditis) and nosologically defined systemic autoimmune diseases and vasculitis. Isolated post-COVID aortitis is one of the rarest complications of SARS-CoV-2 infection. We present a clinical observation of a patient with myocarditis and aortitis simultaneously developing 1 month after COVID-19 with damage to the infrarenal section and formation of an aortic aneurysm. Myocarditis was verified by MRI, manifested by severe dysfunction of the left ventricle with a drop in the ejection fraction to 30% and was of an autoimmune nature (a 4-fold increase in the titers of anticardiac antibodies was revealed). At the same time, MSCT revealed an aortic aneurysm with thickening of its walls. Therapy with medium doses of corticosteroids resulted in clinical remission of myocarditis, but progression of the aortic aneurysm required surgical treatment. The diagnosis of chronic immune inflammation associated with SARS-CoV-2 was morphologically confirmed (nucleocapsid and spike proteins of the virus were detected in macrophages, lymphocytes of infiltrates and endothelium of microvessels). The combination of post-COVID myocarditis and chronic aortitis has not been described previously. The issues of pathogenesis, diagnostics, and nosological nature of combined immune-inflammatory damage to the heart and blood vessels after a new coronavirus infection are discussed.

新型冠状病毒感染不仅在急性期表现为明显的细胞因子和自身免疫反应,而且是一系列慢性免疫炎症的诱导剂,从所谓的“后冠状病毒综合征”的一般表现到单器官疾病(包括心肌炎)和病理性定义的系统性自身免疫性疾病和血管炎,这些疾病在不同程度上具有不同的特异性。孤立的冠状病毒后主动脉炎是SARS-CoV-2感染最罕见的并发症之一。我们报告1例新型冠状病毒感染后1个月同时发生心肌炎和主动脉炎,并伴有肾下段损伤和主动脉瘤形成的临床观察。MRI证实心肌炎,表现为左心室严重功能障碍,射血分数下降至30%,并具有自身免疫性(显示抗心脏抗体滴度增加4倍)。同时,MSCT显示主动脉瘤壁增厚。中剂量皮质类固醇治疗导致心肌炎的临床缓解,但主动脉瘤的进展需要手术治疗。形态学证实诊断为SARS-CoV-2相关的慢性免疫炎症(在巨噬细胞、浸润淋巴细胞和微血管内皮中检测到病毒的核衣壳和刺突蛋白)。covid - 19后心肌炎合并慢性主动脉炎的情况此前未见报道。本文讨论了新型冠状病毒感染后心脏和血管免疫-炎症联合损伤的发病机制、诊断和分类学性质等问题。
{"title":"[Post-Covid aortitis with cardiac involvement: progressive aortic aneurysm combined with active myocarditis].","authors":"O V Blagova, P O Savina, E A Kogan","doi":"10.17116/patol20258702153","DOIUrl":"https://doi.org/10.17116/patol20258702153","url":null,"abstract":"<p><p>The new coronavirus infection is characterized not only by pronounced cytokine and autoimmune reactions in the acute period, but is also an inducer of a whole spectrum of chronic immunoinflammatory conditions, which differ in varying degrees of specificity from general manifestations of the so-called post-COVID syndrome to single-organ diseases (including myocarditis) and nosologically defined systemic autoimmune diseases and vasculitis. Isolated post-COVID aortitis is one of the rarest complications of SARS-CoV-2 infection. We present a clinical observation of a patient with myocarditis and aortitis simultaneously developing 1 month after COVID-19 with damage to the infrarenal section and formation of an aortic aneurysm. Myocarditis was verified by MRI, manifested by severe dysfunction of the left ventricle with a drop in the ejection fraction to 30% and was of an autoimmune nature (a 4-fold increase in the titers of anticardiac antibodies was revealed). At the same time, MSCT revealed an aortic aneurysm with thickening of its walls. Therapy with medium doses of corticosteroids resulted in clinical remission of myocarditis, but progression of the aortic aneurysm required surgical treatment. The diagnosis of chronic immune inflammation associated with SARS-CoV-2 was morphologically confirmed (nucleocapsid and spike proteins of the virus were detected in macrophages, lymphocytes of infiltrates and endothelium of microvessels). The combination of post-COVID myocarditis and chronic aortitis has not been described previously. The issues of pathogenesis, diagnostics, and nosological nature of combined immune-inflammatory damage to the heart and blood vessels after a new coronavirus infection are discussed.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"87 2","pages":"53-58"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143952742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arkhiv patologii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1